Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Parasit Vectors. 2024 Jun 28;17(1):276. doi: 10.1186/s13071-024-06347-w.
ABSTRACT
BACKGROUND: Female Aedes aegypti mosquitoes can spread disease-causing pathogens when they bite humans to obtain blood nutrients required for egg production. Following a complete blood meal, host-seeking is suppressed until eggs are laid. Neuropeptide Y-like receptor 7 (NPYLR7) plays a role in endogenous host-seeking suppression and previous work identified small-molecule NPYLR7 agonists that inhibit host-seeking and blood-feeding when fed to mosquitoes at high micromolar doses.
METHODS: Using structure-activity relationship analysis and structure-guided design we synthesized 128 compounds with similarity to known NPYLR7 agonists.
RESULTS: Although in vitro potency (EC50) was not strictly predictive of in vivo effect, we identified three compounds that reduced blood-feeding from a live host when fed to mosquitoes at a dose of 1 μM-a 100-fold improvement over the original reference compound.
CONCLUSIONS: Exogenous activation of NPYLR7 represents an innovative vector control strategy to block mosquito biting behavior and prevent mosquito-human host interactions that lead to pathogen transmission.
PMID:38937807 | DOI:10.1186/s13071-024-06347-w
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
Next-generation neuropeptide Y receptor small-molecule agonists inhibit mosquito-biting behavior
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
AI-driven convolutional neural networks for accurate identification of yellow fever vectors AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1 Discovery of 3-((4-Benzylpyridin-2-yl)amino)benzamides as Potent GPR52 G Protein-Biased Agonists IUPHAR review - Glucagon-like peptide-1 (GLP-1) and substance use disorders:An emerging pharmacotherapeutic target Postoperative use of sleep aids and delirium in older adults after major surgery: A retrospective cohort study The Efficacy of GLP-1 Agonists in Treating Substance Use Disorder in Patients: A Scoping Review The Efficacy of GLP-1 Agonists in Treating Substance Use Disorder in Patients: A Scoping Review Effects of Selective and Mixed-Action Kappa and Delta Opioid Receptor Agonists on Pain-Related Behavioral Depression in Mice Discovery of Novel, Selective, and Nonbasic Agonists for the Kappa-Opioid Receptor Determined by Salvinorin A-Based Virtual Screening Underlying mechanisms for psychotropic effects of delta opioid receptor agonists A µ-opioid receptor modulator that works cooperatively with naloxone The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology P-glycoprotein activity in vivo in older adults: physiological, pathophysiological and pharmacokinetic interplay at the blood-brain barrier Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data Neural circuits expressing the serotonin 2C receptor regulate memory in mice and humans Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer's disease Efficacy in diet-induced obese mice of the hepatotropic, peripheral cannabinoid 1 receptor inverse agonist TM38837 Diabetes drugs activate neuroprotective pathways in models of neonatal hypoxic-ischemic encephalopathy Chronic treatment with glucagon-like peptide-1 and glucagon receptor co-agonist causes weight loss-independent improvements in hepatic steatosis in mice with diet-induced obesity Impulse control disorders and use of dopamine agonists in early onset Parkinson's disease Impulse control disorders and use of dopamine agonists in early onset Parkinson's disease Impulse control disorders and use of dopamine agonists in early onset Parkinson's disease GLP-1 agonists and risk of suicidal thoughts and behaviours: Confound by indication once again? A narrative review Development of novel tools for dissection of central versus peripheral dopamine D2-like receptor signaling in dysglycemia Development of a genetically encoded sensor for probing endogenous nociceptin opioid peptide release Development of a genetically encoded sensor for probing endogenous nociceptin opioid peptide release The Alk receptor tyrosine kinase regulates Sparkly, a novel activity regulating neuropeptide precursor in the Drosophila central nervous system Ectonucleotidase Activity in Smooth Muscle Tissues of Rats with a Valproate Model of Autism Elafibranor PPARα/δ Dual Agonist Ameliorates Ovalbumin-Induced Allergic Asthma DRD4 gene polymorphism and impulse control disorder induced by dopamine agonists in Parkinson's disease Cerebellar damage with inflammation upregulates oxytocin receptor expression in Bergmann Glia Activation of Neuropeptide Y (NPY) receptors in the basolateral amygdala (BLA) inhibits projections to the bed nucleus of the stria terminalis (BNST) and buffers stress-induced decreases in social interaction in male rats The role of fatty acid-binding protein 5 and 7 on locomotor, anxiety and social behavior: Interaction with NMDA signaling The role of fatty acid-binding protein 5 and 7 on locomotor, anxiety and social behavior: Interaction with NMDA signaling Generative design of compounds with desired potency from target protein sequences using a multimodal biochemical language model Efficacy and tolerability of brexpiprazole - a new antipsychotic drug from the group of dopamine D2 receptor partial agonists Efficacy and tolerability of brexpiprazole - a new antipsychotic drug from the group of dopamine D2 receptor partial agonists Glucagon-like peptide receptor agonists and risk for depression Glucagon-like peptide receptor agonists and risk for depression Assessing suicide risk in chronic pain management: a narrative review across drug classes Mapping the molecular motions of 5-HT3 serotonin-gated channel by voltage-clamp fluorometry Neuropeptide Y receptor activation preserves inner retinal integrity through PI3K/Akt signaling in a glaucoma mouse model Neuropeptide Y receptor activation preserves inner retinal integrity through PI3K/Akt signaling in a glaucoma mouse model Summary for Patients: Glucagon-Like Peptide-1 Receptor Agonists and Risk for Suicidal Ideation and Behaviors in U.S. Older Adults With Type 2 Diabetes Development of VU6036864: A Triazolopyridine-Based High-Quality Antagonist Tool Compound of the M5 Muscarinic Acetylcholine Receptor GLP-1 receptor agonists and weight loss in schizophrenia - past, present, and future Preclinical in vitro and in vivo results of the new silk vista flow diverter with P8RI coating Chemerin in caudal division of nucleus tractus solitarius increases sympathetic activity and blood pressure Alpha2 Agonist Use in Critically Ill Adults: A Focus on Sedation and Withdrawal Prevention Ventral tegmental area amylin receptor activation differentially modulates mesolimbic dopamine signaling in response to fat versus sugar Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study Cavbeta3 Contributes to the Maintenance of the Blood-Brain Barrier and Alleviates Symptoms of Experimental Autoimmune Encephalitis Heparan sulfate acts as an activator of the NLRP3 inflammasome promoting inflammatory response in the development of acute pancreatitis Cryo-EM structures elucidate the multiligand receptor nature of megalin Glutamate neurotransmission from leptin receptor cells is required for typical puberty and reproductive function in female mice Optimizing GABAA receptor antagonism for the induction of long-term potentiation in the mouse and rat dentate gyrus in vitro A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for In Vivo Studies A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for In Vivo Studies Transcriptomic Analysis of Metastatic Uveal Melanoma and Differences in Male and Female Patients Assessing the Effects of Thiazole-Carboxamide Derivatives on the Biophysical Properties of AMPA Receptor Complexes as a Potential Neuroprotective Agent
Evidence Blueprint
Next-generation neuropeptide Y receptor small-molecule agonists inhibit mosquito-biting behavior
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Next-generation neuropeptide Y receptor small-molecule agonists inhibit mosquito-biting behavior
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
Suicidal Thoughts and Self-injurious Behavior Associated With Glucagon-Like Peptide-1 Receptor Agonists - A Review PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease AI-driven convolutional neural networks for accurate identification of yellow fever vectors Identification of 1,3,8-triazaspiro[4.5]decane-2,4-dione Derivatives as a Novel Delta Opioid Receptor-Selective Agonist Chemotype AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1 Discovery of 3-((4-Benzylpyridin-2-yl)amino)benzamides as Potent GPR52 G Protein-Biased Agonists Development of bile acid activated receptors hybrid molecules for the treatment of inflammatory and metabolic disorders NCP, a dual kappa and mu opioid receptor agonist, is a potent analgesic against inflammatory pain without reinforcing or aversive properties IUPHAR review - Glucagon-like peptide-1 (GLP-1) and substance use disorders:An emerging pharmacotherapeutic target All-Hydrocarbon Stapled Peptide Multifunctional Agonists at Opioid and Neuropeptide FF Receptors: Highly Potent, Long-Lasting Brain Permeant Analgesics with Diminished Side Effects Experimental and computational biophysics to identify vasodilator drugs targeted at TRPV2 using agonists based on the probenecid scaffold Inhibition of neuraminidase-1 sialidase activity by interfering peptides impairs insulin receptor activity in vitro and glucose homeostasis in vivo Postoperative use of sleep aids and delirium in older adults after major surgery: A retrospective cohort study The Efficacy of GLP-1 Agonists in Treating Substance Use Disorder in Patients: A Scoping Review The Efficacy of GLP-1 Agonists in Treating Substance Use Disorder in Patients: A Scoping Review Effects of Selective and Mixed-Action Kappa and Delta Opioid Receptor Agonists on Pain-Related Behavioral Depression in Mice Discovery of a CB2 and 5-HT1A receptor dual agonist for the treatment of depression and anxiety The Effects of Chronic Naltrexone on Reinstatement of Opioid-Induced Drug-Seeking Behavior and Antinociception Mechanisms of biased agonism by Gαi/o-biased stapled peptide agonists of the relaxin-3 receptor Estradiol and Mu opioid-mediated reward: The role of estrogen receptors in opioid use Cholecystokinin B receptor agonists alleviates anterograde amnesia in cholecystokinin-deficient and aged Alzheimer's disease mice Identification of 3H-benzo[b] [1,4] diazepine derivatives as PPARα agonists by in silico studies and biochemical evaluation Discovery of Novel, Selective, and Nonbasic Agonists for the Kappa-Opioid Receptor Determined by Salvinorin A-Based Virtual Screening µ-Opioid receptor antagonism facilitates the anxiolytic-like effect of oxytocin in mice Underlying mechanisms for psychotropic effects of delta opioid receptor agonists Discovery and in vitro Evaluation of Novel Serotonin 5-HT2A Receptor Ligands Identified Through Virtual Screening A µ-opioid receptor modulator that works cooperatively with naloxone Fasting upregulates the monocarboxylate transporter MCT1 at the rat blood-brain barrier through PPAR delta activation A retrospective clinical practice study comparing the usefulness of dual-orexin receptor antagonists and a melatonin receptor agonist in patients switching from long-term benzodiazepine receptor agonists Structural pharmacology and therapeutic potential of 5-methoxytryptamines Structural pharmacology and therapeutic potential of 5-methoxytryptamines The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology P-glycoprotein activity in vivo in older adults: physiological, pathophysiological and pharmacokinetic interplay at the blood-brain barrier Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data Augmentation therapy with serotonin1A receptor partial agonists on neurocognitive function in schizophrenia: A systematic review and meta-analysis Neural circuits expressing the serotonin 2C receptor regulate memory in mice and humans Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer's disease The emerging role of glucagon-like peptide-1 in binge eating The emerging role of glucagon-like peptide-1 in binge eating Glucocorticoid receptor modulator CORT125385 alleviates diet-induced hepatosteatosis in male and female mice Synthesis and biochemical evaluation of 17-N-beta-aminoalkyl-4,5α-epoxynormorphinans Efficacy in diet-induced obese mice of the hepatotropic, peripheral cannabinoid 1 receptor inverse agonist TM38837 Melanocortin agonism in a social context selectively activates nucleus accumbens in an oxytocin-dependent manner Discriminative stimulus properties of Cannabis sativa terpenes in rats Sub-second Dopamine Signals during Risky Decision-Making in Patients with Impulse Control Disorder Possible involvement of FFAR1 signaling in mouse emotional behaviors through the regulation of brain monoamine releases PPAR-γ agonists reactivate the ALDOC-NR2F1 axis to enhance sensitivity to temozolomide and suppress glioblastoma progression Functions and pharmacology of α2β2 nicotinic acetylcholine receptors; in and out of the shadow of α4β2 nicotinic acetylcholine receptors Diabetes drugs activate neuroprotective pathways in models of neonatal hypoxic-ischemic encephalopathy 4-Amidophenol Quinone Methide Precursors: Effective and Broad-Scope Nonoxime Reactivators of Organophosphorus-Inhibited Cholinesterases and Resurrectors of Organophosphorus-Aged Acetylcholinesterase Biguanides and glucagon like peptide 1 receptor agonists in the amelioration of post liver transplant weight gain; a scoping review of the mechanism of action, safety and efficacy Chronic treatment with glucagon-like peptide-1 and glucagon receptor co-agonist causes weight loss-independent improvements in hepatic steatosis in mice with diet-induced obesity Semaglutide combined with empagliflozin vs. monotherapy for non-alcoholic fatty liver disease in type 2 diabetes: Study protocol for a randomized clinical trial Optogenetic determination of dynamic and cell-type-specific inhibitory reversal potentials GFP and FAP imaging of neuropeptide release in Drosophila Impulse control disorders and use of dopamine agonists in early onset Parkinson's disease Impulse control disorders and use of dopamine agonists in early onset Parkinson's disease Impulse control disorders and use of dopamine agonists in early onset Parkinson's disease Discovery of LH10, a novel fexaramine-based FXR agonist for the treatment of liver disease Sex differences and sex-specific regulation of motivated behavior by Melanin-concentrating hormone: a short review